Long Noncoding RNA GAS5 Suppresses Tumorigenesis by Inhibiting miR-23a Expression in Non-Small Cell Lung Cancer

Area of Science:

• Molecular Biology
• Oncology
• RNA Biology

Background:

• Previous studies suggested long noncoding RNA GAS5 (lncRNA GAS5) inhibits non-small cell lung cancer (NSCLC) progression.
• The precise molecular mechanisms underlying lncRNA GAS5's role in NSCLC remain incompletely understood.

Purpose of the Study:

• To investigate the molecular mechanism of lncRNA GAS5 in NSCLC.
• To explore the relationship between lncRNA GAS5 and miR-23a in NSCLC.
• To evaluate the therapeutic potential of lncRNA GAS5 in NSCLC.

Main Methods:

• Quantitative real-time PCR (qRT-PCR) and luciferase reporter assays were used to analyze the interaction between GAS5 and miR-23a.
• In vitro cell proliferation, invasion, and apoptosis assays were performed.
• In vivo xenograft experiments in nude mice were conducted to assess tumor growth inhibition.

Main Results:

• GAS5 was found to be downregulated in NSCLC tissues and negatively correlated with miR-23a expression.
• GAS5 directly interacted with and inhibited miR-23a expression.
• Overexpression of GAS5 inhibited NSCLC cell proliferation and invasion while promoting apoptosis, effects abolished by miR-23a.
• Upregulation of GAS5 suppressed tumor growth in vivo by inhibiting miR-23a.

Conclusions:

• lncRNA GAS5 suppresses NSCLC tumorigenesis by inhibiting miR-23a.
• GAS5 represents a potential therapeutic target for NSCLC treatment.